LenioBio

At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry

Protein expression,protein production,synthetic biology,biotechnology,membrane proteins,antibodies,functional proteins,sustainable foods,vaccines,therapeutic proteins,structural biology,cell-free protein production,cell-free protein expression,and plant-based protein

Leniobio operates in the Biotechnology research industry.

Leniobio's revenue is 11m - 100m

Leniobio has 51 - 200 employees.